JP2020519593A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519593A5
JP2020519593A5 JP2019561320A JP2019561320A JP2020519593A5 JP 2020519593 A5 JP2020519593 A5 JP 2020519593A5 JP 2019561320 A JP2019561320 A JP 2019561320A JP 2019561320 A JP2019561320 A JP 2019561320A JP 2020519593 A5 JP2020519593 A5 JP 2020519593A5
Authority
JP
Japan
Prior art keywords
acid
aqueous composition
composition according
acids
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019561320A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2018/050511 external-priority patent/WO2018207188A1/en
Publication of JP2020519593A publication Critical patent/JP2020519593A/ja
Publication of JP2020519593A5 publication Critical patent/JP2020519593A5/ja
Pending legal-status Critical Current

Links

JP2019561320A 2017-05-11 2018-05-10 溶解度を増強させた薬物含有製剤 Pending JP2020519593A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762504546P 2017-05-11 2017-05-11
US62/504,546 2017-05-11
PCT/IL2018/050511 WO2018207188A1 (en) 2017-05-11 2018-05-10 Enhanced solubility drug-containing formulations

Publications (2)

Publication Number Publication Date
JP2020519593A JP2020519593A (ja) 2020-07-02
JP2020519593A5 true JP2020519593A5 (enExample) 2021-07-26

Family

ID=62599659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019561320A Pending JP2020519593A (ja) 2017-05-11 2018-05-10 溶解度を増強させた薬物含有製剤

Country Status (9)

Country Link
US (1) US11672863B2 (enExample)
EP (1) EP3621591A1 (enExample)
JP (1) JP2020519593A (enExample)
KR (1) KR20200018438A (enExample)
CN (1) CN110869000A (enExample)
AU (1) AU2018265624A1 (enExample)
CA (1) CA3063322A1 (enExample)
IL (1) IL271673A (enExample)
WO (1) WO2018207188A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200018438A (ko) 2017-05-11 2020-02-19 스테디메드 리미티드 향상된 용해도의 약물-함유 제형
KR102891439B1 (ko) * 2019-08-01 2025-11-25 인카다 테라퓨틱스, 인크. 항부정맥 제제

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910260A (en) 1972-03-01 1975-10-07 Survival Technology Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care
US4004577A (en) 1972-12-04 1977-01-25 Survival Technology, Inc. Method of treating heart attack patients prior to the establishment of qualified direct contact personal care
US3941130A (en) 1975-03-18 1976-03-02 Tibbs Robert C Sequential trigger release for injection device
US4261358A (en) 1979-10-01 1981-04-14 Walter Vargas Automatic syringe plunger
US4795433A (en) 1985-05-20 1989-01-03 Survival Technology, Inc. Automatic injector for emergency treatment
US4689042A (en) 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
US4902692A (en) * 1988-03-18 1990-02-20 Iolab Corporation Method and composition for ophthalmic anesthesia using rodocaine
US5102393A (en) 1989-07-17 1992-04-07 Survival Technology, Inc. Autoinjector converted from intramuscular to subcutaneous mode of injection
US5085642A (en) 1989-07-17 1992-02-04 Survival Technology, Inc. Conveniently carried frequent use autoinjector
US5092843A (en) 1990-04-12 1992-03-03 Survival Technology, Inc. Dispersion multichamber auto-injector
US5267963A (en) 1992-08-21 1993-12-07 Nicholas Bachynsky Medication injection device
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
DE69331387T2 (de) * 1992-09-10 2002-08-22 Childrens Medical Center Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
EP2198854B1 (en) * 1997-09-18 2011-11-30 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US6149626A (en) 1997-10-03 2000-11-21 Bachynsky; Nicholas Automatic injecting syringe apparatus
SE9803662D0 (sv) 1998-10-26 1998-10-26 Pharmacia & Upjohn Ab Autoinjector
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
CN103316402A (zh) 2006-06-30 2013-09-25 艾伯维生物技术有限公司 自动注射装置
CN101744760A (zh) * 2008-12-18 2010-06-23 梁颖 用于难溶性或易分解性药物的缓释体
CN102106806B (zh) * 2009-12-29 2013-04-17 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
JP6544749B2 (ja) * 2014-07-15 2019-07-17 オディディ,イサ 過量服用を減らすための組成物および方法
AU2016352007B2 (en) * 2015-11-12 2022-03-17 Terumo Kabushiki Kaisha Sustained-release topically administered agent
KR20200018438A (ko) 2017-05-11 2020-02-19 스테디메드 리미티드 향상된 용해도의 약물-함유 제형

Similar Documents

Publication Publication Date Title
AR043057A1 (es) Compuestos derivados de piridintiazoles como inhibidores de la quinasa rock y otras proteinas quinasa
JP2020519593A5 (enExample)
NO20084403L (no) Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I
CY1111934T1 (el) Σταθεροποιημενες φαρμακευτικες συνθεσεις οι οποιες περιεχουν φεσοτεροδινη
CY1118292T1 (el) Ρυθμιστες φαρμακοκινητικων ιδιοτητων των θεραπευτικων
PE20091785A1 (es) Sales de adicion de acido de piperidin-4-ilamida del acido 4-(2,6-dicloro-benzoil-amino)-1h-pirazol-3-carboxilico
JP2015518903A5 (enExample)
EA200801245A1 (ru) [4-(6-галоген-7-замещенные-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины и формы и способы, связанные с ними
Patrick et al. Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense
RU2015146417A (ru) Пероральная фармацевтическая композиция для профилактики или лечения синдрома "сухого глаза", содержащая ребамипид или его предшественник
NO20075920L (no) Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria
BRPI1011804A2 (pt) composição farmacêutica com solubilidade melhorada
JP2019522037A5 (enExample)
JP2012518649A5 (enExample)
EA201892687A1 (ru) Кристаллическая форма соединения, подавляющего активность протеинкиназы, и её применение
Sadafule et al. Comparative study of efficacy of preoperative nalbuphine hydrochloride and pentazocine lactate on hemodynamic response to tracheal intubation and postoperative analgesia
JOP20170197B1 (ar) الصيغة الجديدة التي تشتمل على مشتق بنزيميدازول
CY1111129T1 (el) Στερεη φαρμακευτικη ενωση που περιεχει τελιθρομυκινη
JP2021042159A5 (enExample)
JP2015512948A5 (enExample)
MX2015009268A (es) Isomero de isometepteno.
RU2018100116A (ru) Дейтерированные производные тиенопиперидина, способ их получения и применение
JP2006506413A5 (enExample)
RU2014152454A (ru) Производное никотинамида в лечении острого коронарного синдрома
CN1297265C (zh) 抗血栓形成药与阿司匹林的新组合及其在制备用于治疗动脉粥样硬化血栓形成性疾病的药物中的用途